There is also increasing evidence that the NF-κB signaling pathway was abnormally activated in various cancer cell lines including CRC, with the silencing of NF-κB signaling pathway significantly inhibiting cell proliferation and migration of CRC in vitro (Soleimani et al., 2020). The gene discussed is NFKB1; the disease is cancer.